Ads
related to: novavax stock price target
Search results
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 1 hour agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
PVH (NYSE:PVH) Price Target Increased to $120.00 by Analysts at Morgan Stanley
ETF DAILY NEWS· 13 hours agoPVH (NYSE:PVH – Free Report) had its price target boosted by Morgan Stanley from $110.00 to $120.00 in a research report released on Thursday morning, Benzinga ...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 23 hours agoOn Wednesday, Novavax said it plans to launch an updated booster to target the JN.1 variant, in line...
IDACORP, Inc. (NYSE:IDA) Receives $97.40 Average Target Price from Analysts
ETF DAILY NEWS· 17 hours agoFive investment analysts have rated the stock with a hold rating. Wells Fargo & Company lifted their price target on shares of IDACORP ...
Novavax Stock Soars On FDA COVID-19 Update: Fundamental Rally Or Potential Short Squeeze? - Novavax...
Benzinga· 1 day agoNovavax, Inc. NVAX is back in the spotlight as its stock skyrockets following a wave of positive...
Analysts Set Revvity, Inc. (NYSE:RVTY) Target Price at $117.92
ETF DAILY NEWS· 17 hours agoSeven research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
InvestorPlace· 8 hours agoIn a meme frenzy, any positive news related to a company has a magnified impact on the stock price....
Steward Partners Investment Advisory LLC Has $435,000 Stock Holdings in Graco Inc. (NYSE:GGG)
ETF DAILY NEWS· 13 hours agoThe firm owned 5,018 shares of the industrial products company’sstock after purchasing an additional...
Morgan Stanley Increases Hewlett Packard Enterprise (NYSE:HPE) Price Target to $21.00
ETF DAILY NEWS· 17 hours agoPackard Enterprise (NYSE:HPE – Get Free Report) had its price target lifted by Morgan Stanley from $19.00 to $21.00 in a report released on Wednesday, Benzinga ...
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $21.00 at Barclays
ETF DAILY NEWS· 16 hours agoBank of America raised their price target on shares of Teva Pharmaceutical Industries from $18.00 to $21.00 and gave the stock a “buy ...